In addition, modern research has found that the SRC family tyrosine kinase is a core target receptor for neurodegenerative diseases [33], and the genetic polymorphism of the estrogen receptor (ESR) also has a strong correlation with AD [34], making it a potential therapeutic intervention target for neurodegenerative diseases. This evidence concerns the gene SRC and Alzheimer disease.